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Abstract: Cone-beam CT (CBCT) application to the field of trans-arterial chemoembolization has been 
recently the focus of several researches. This imaging modality is performed with a rotation of the C-arm 
around the patient, without needs of patient repositioning. Datasets are immediately processed, obtaining 
volumetric CT-like images with the possibility of post-processing and reconstruction of images. Dual phase 
CBCT recently introduced in clinical practice consists in a first arterial acquisition followed by a delayed 
acquisition corresponding to a venous phase. The introduction of this feature has overcome the limit of 
single-phase acquisitions, allowing lesions characterization. Moreover these recent advantages have several 
intra-procedural implications. Detailed technical and acquisition parameters will be widely exposed in this 
review with particular attention to: catheter positioning, acquisition delay, injection parameters, patient 
positioning and contrast dilution. Comparison with standard of practice second line imaging [multidetector 
computer tomography (MDCT) and MDCT/arteriography] demonstrate the capability of detecting 
occult nodules providing some clinical implications thus potentially identifying a sub set of patients with 
aggressive disease behaviour. Other intra-procedural advantages of dual phase CBCT usage consist in a 
better tumor feeder visualization, reduction of proper DSA and fluoroscopic time, suggestion the presence 
of an extrahepatic parasitic feeder thus resulting in a more accurate treatment. Finally, the volumetrical 
intraprocedural evaluation of accumulation of embolic agent has proved to be correlate with treatment 
response if compared with MRI. 
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Introduction
According to international guidelines catheter based 
treatment represent the standard of care for both 
intermediate and advanced hepatocellular carcinoma 
(HCC) (1) .  Different aim could be pursued with 
transarterial therapies: intermediate stage benefits of 
local tumor debulking in order to keep patient within an 
active list for orthotopic liver transplantation (bridging 
to transplantation); whereas when dealing with advanced 
stage HCC, catheter based approach could in selected cases 
downstage total tumor burden in order to perform potential 
curative approach (major resection) (2-4). 
Cone-beam CT (CBCT) is a volumetric imaging 
modal i ty,  prov ided  by  a l l  d i f ferent  Angio  Sui te 
manufacturer, obtained by a single rotation of the C-arm 
flat panel detector around the patient. The acquisition is 
performed directly on the Angio Suite table, without need 
of patient repositioning, with or without contrast media 
administration. Immediate processing of acquired dataset 
lead to visualization, on dedicated workstation, of CT-
like images, that ensure perfect cross-sectional comparison 
with standard contrast enhanced multidetector computer 
tomography (MDCT) or MRI on which all procedures 
are nowadays planned. Since its first usage within the 
neuro-interventional field (5,6), growing evidence of its 
adjunctive diagnostic value was reported even for peripheral 
applications: to assist below the knee revascularization 
procedures (7); as guidance for combined hybrid procedure 
(embolization + percutaneous ablation) for single or 
multiple lesions (8); to intraprocedural aid detection and 
correction of type Ia endoleak after EVAR procedures (9); 
to assist portal vein embolization procedures (10). 
The application of this newly introduced imaging 
technique to the field of liver transcatheter oncological 
treatments, has significantly changed everyday practice. 
In fact, by aiding detection of the vasculature path to be 
catheterized to perform the embolization (detection of 
intrahepatic feeder) (11-13), by demonstrating the presence 
of extra hepatic feeders (14) as well as the presence of 
occult nodules missed at standard second line imaging 
had dramatically improved the outcome of treatment (15). 
Moreover, the routinely usage of this imaging modality, 
permits reduction of the total radiation dose for both 
operator and patient and reduction of the total amount of 
contrast media administered (16). 
The aim of this review is to present all clinical and 
procedural advantages of the introduction of CBCT 
technique as guidance for all liver oncological catheter 
based procedures.
CBCT technique 
CBCT imaging can be performed only with new 
generation flat panel angiographers featuring dedicated 
imaging reconstruction software, as provided by different 
manufacturers (DynaCT, Siemens; XperCT, Philips; Innova 
CT, GE Healthcare). The acquisition is performed, without 
need of patient repositioning, either before or after the 
embolization procedure. In a single orbit the C-arm rotates 
178–220° around the patient, whit acquisition times ranging 
between 5 and 20 seconds, acquiring images every 0.39–0.52° 
with a pitch of 200–800 micron at 15–60 frame/second. The 
acquired rotational angiography displayed on the conventional 
monitor is immediately processed in order to create volumetric 
CT datasets (images range 24–35 cm, matrix size 512 cm 
× 512 cm ×387 cm, for a total amount of images around 
400–420, with a matrix and isotropic resolution of 0.49 mm 
with a FOV ranging between 12–40 cm). The high resolution 
of these images permits 3D reconstructions (including 
multiplanar reformations, maximum intensity projections 
and volume rendering images). The acquisition is performed 
with continuous modulation of the tube current, allowing for 
estimated dose around 3–10 mSv for a single CBCT.
The major advantages of this technique derive from 
its ability to combine contrast media injection with three-
dimensional CT-like images, overcoming the classical limit 
of bi-dimensional proper digital subtraction angiography 
(DSA) acquisition. The contrast media intra-arterial injection 
maximizes the discrepancy measured in term of contrast to 
noise ratio (CNR) and signal to noise ratio (SNR) between 
the healthy liver and HCC nodules. In detail first proper 
DSA acquisitions (posteroanterior and right anterior oblique 
projections) are performed in order to verify the appropriate 
flow and volume of the power injector (e.g., small vasculature 
2.7–3 mL/s, total volume 12 mL; hypertrophied vasculature 
4 mL/s, total volume 20 mL); injection could be performed 
either with via the standard 4–5 Fr angiographic catheter 
positioned in the proper hepatic artery (suggested PSI limit 
900), yielding to a complete liver parenchima enhancement, 
or via a superselective positioned microcatheter (suggested 
PSI limit 600) visualizing just the segment/lobe of interest. 
Once the velocity of injection is identified (based on DSA 
findings), single injection dual phase CBCT is performed by 
setting appropriate injection duration and acquisition delay, 
with diluted contrast media (ratio 1:3). In fact, the injection 
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duration should cover the acquisition time (around 7 seconds 
of rotation) and the 8 seconds of delay needed to gain optimal 
liver parenchyma enhancement, yielding to total injection 
duration of 15 seconds. Delayed phase CBCT is acquired 
within 30 seconds from the first acquisition. By employing 
these technical specifications (duration of injection and 
delay of acquisition) first CBCT acquisition combine the 
liver vasculature visualization with appropriate parenchyma/
nodule enhancement. The added value of the second CBCT 
acquisition is represented by the potentiality of characterizing 
lesion by depicting their behaviour (e.g., lesion’s washout). 
Figure 1 summarizes the technical detail of the dual-phase 
technique.
Comparison with MDCT/MDCT arteriography
As compared to conventional MDCT acquisitions, CBCT 
present some significant limitations in terms of image 
quality, mostly related to the increased photon scatter 
and increase image noise generated by the small FOV. 
Notwithstanding these limitations, recently published 
papers demonstrate that the clinical performance of CBCT 
(in terms of tumor identification, vessel delineation and soft 
tissue evaluation) isn’t significantly impaired as compared to 
that of conventional CT (Figure 2). 
Regarding the major constrain of the limited FOV 
dimension, is worth to underline that most of patients 
usually fits even with this limited field of view. In several 
particular settings, such as hypertrophied left liver lobe, 
obese patients this could became a major limitation. In 
order to solve this technical drawback: “open arc cone-beam 
CT” has been recently reported, by modifying the axis of 
rotation of the c-arm around the patient in order to image 
all the live segments within a single acquisition (17). 
3D acquisition
Start contrast
Arterial phase
Washout 
phase8 s
6 s
within 30 s
X-ray delay
4 mL/s 2 mL/s
End contrast
3D acquisition
Figure 1 Summary of dual-phase CBCT technical detail with respect to acquisition optimal delay and selection of best power injector 
parameter obtained on the basis of standard DSA adjusted according to different liver vasculature dimension. CBCT, cone-beam CT; DSA, 
digital subtraction angiography.
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Despite these over mentioned technical limits in 
clinical practice CBCT can permit to shows additional 
HCC if compared with MDCT; in fact, recent published 
paper reported higher sensitivity in detection of nodules. 
In particular Mayer et al. (18) demonstrated a specificity 
of 99% and of 85% in tumor detection despite the gold 
standard of reference is not clear being the standard 
of reference the blind reading of the pre-procedural 
MDCT; other authors demonstrate the superiority of 
CBCT in the detection accuracy of nodules smaller 
than 10 mm and the higher sensitivity in nodule smaller 
than 20 mm whereas no differences were observable in 
detection of nodules greater than 10 mm (19); although 
the paper of Higashihara et al. (20) demonstrate no 
significant differences between the mean PPV for 
MDCT and CBCT among <10 and >10 mm group 
despite the number of total HCC detected was greater 
in CBCT group; it’s necessary to mention that in these 
last two paper the standard of reference was considered 
as the accumulation of lipiodol observable at CT imaging 
1 week after the procedure. 
To our knowledge to date there is only one paper focused 
on comparing CBCT with the hybrid CT/Angiography 
suite (21). The paper does not provide a comparison of 
clinical results but analyses advantages or disadvantages 
of every system. In particular, advantages provided by 
using CT instead of flat-panel C-arm regards the larger 
FOV with the certainty of includes the entire liver in 
the acquisition and the less evidence of motion or beam 
hardening artifacts; on the other hand, the patient radiation 
exposure is higher (22) and the cost of the system that is 
1.5–2 times more expensive than CBCT. Despite these 
advantages of hybrid CT/angiography suite, this technology 
has not been widespread across countries, mainly due to 
the high equipment costs. For these reasons comparison 
between techniques is not possible. The other proposed 
technique, mainly reported by Asiatic literature (23-25), 
consist in a MDCT acquisition after having positioned one 
or two arterial catheters within the hepatic and superior 
mesenteric arteries, named MDCT-angiography. Despite 
the known advantages of higher image quality when 
utilizing the MDCT-angiography, these techniques need 
patient repositioning, higher radiation dose and finally 
did not permit any catheter repositioning. Moreover, in 
the reported series the total volume of contrast media 
administered throughout the examination in up to ten times 
more than then one suggested by our single injection dual 
phase imaging protocol.
Intraprocedural implications 
The routine usage of CBCT during chemoembolization 
lead to several advantages: detection of occult nodules, 
better feeding vessels depiction, identification of 
extrahepatic parasitic feeder, sparing of non-target feeder, 
prediction of treatment outcome, reduction of both contrast 
media and radiation dose.
Regarding nodule detection, there’s a wide evidence that 
CBCT in course of TACE has the ability to demonstrate 
nodules not visualized at pre-operative MDCT and at 
standard DSA. Small HCC detectability, at DSA, depends 
on the size of the tumor and of its vascularization; more in 
particular Miyayama et al. (26) demonstrated that the 95% 
of tumor <1.3 mm not detectable at angiography can be seen 
at CBCT and that the 82% of those “occult” nodules can be 
treated with embolization. Lucatelli at al. (15) demonstrated 
how CBCT was capable to depict an occult nodule rate 
of 11.5% not visualized at pre-procedural MDCT. The 
short interlapsed time between intraprocedural CBCT and 
pre-procedural MDCT underline the potentiality of this 
novel imaging modality in depicting an aggressive subset of 
patients that prompt strictly imaging surveillance, aggressive 
management, prioritization in those patient within an active 
list for transplantation.
Another pivotal point of strength of this technique 
relies in the ability of assist the embolization procedure 
identifying tumor feeding arteries as well as extrahepatic 
parasitic feeder presence (Figure 3). In fact has been 
reported that the number of feeders visualized is higher in 
CBCT that in arteriography alone; in particular Iwazawa 
et al. (27) reported a CBCT sensitivity, specificity and 
accuracy of 96.9%, 97.0% and 96.9% respectively, 
significant higher than those reported for angiography 
(77.2%, 73% and 74.5% respectively); other authors 
confirms these results reporting the number visualized 
of tumor feeders during CBCT and DSA that was 4±1.7 
and 3.3±1.4 respectively with a significative statistical 
evidence between the two imaging techniques (28). 
Recently an “automated tumor feeder detector” has been 
developed and some authors (29) evaluate the technical 
performance of this software; in particular Iwazawa 
et al. (30) reported that the sensitivity of this software 
was significantly higher than the conventional assessment 
using DSA (87.7% vs. 71.8%, P<0.001); on the other 
hand, the software showed low capability to detect 
feeders smaller than 1 mm and feeders adjacent to 
prior lipiodol accumulation. Therefore, the authors 
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Figure 2 A case of an intraprocedural CBCT diagnosis of occult nodule in a patient with a S6 (40 mm) exophytic HCC. MDCT arterial 
(A) and delayed phase (B) shows the presence of the main nodule, with no satellite nodules. Intraprocedural CBCT arterial (C) and venous 
phases (D) demonstrate a satellite nodule (black arrow) with typical behaviour that was intra-procedurally treated. One-month MDCT 
demonstrate complete response (E,F). HCC, hepatocellular carcinoma; MDCT, multidetector computer tomography. 
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conclude that the software has sufficient performance to 
identify tumor-feeders and can contributes to technical 
success in superselective procedure. Finally, Kinoshita 
et al. demonstrated how CBCT guidance aid to spare 
cystic artery when it fed the tumor (31). 
Extrahepatic feeder presence could be supposed, 
especially in patients undergoing several catheters based 
treatment or with lesion located in certain liver areas 
(subcapsular, liver dome, gallbladder bed), in cases were 
CBCT had shown incomplete nodule enhancement (16). 
Moreover, CBCT usage has been correlated with better 
procedural outcome: Wang et al. (32) demonstrated a strong 
correlation between lipiodol deposition on CBCT and 
tumor necrosis (cm3) assessed with enhanced MRI.
Lastly, the routine employment of this novel imaging 
modality by acquiring a CT-like 3D-volume, permitting 
multiplanar reconstruction, aid in the detection of the 
best projection to facilitate catheterization thus sparing 
fluoroscopy time as well as contrast media administration.
Conclusions
CBCT represent the novel standard of care of imaging 
guidance for catheter-based treatments. Its usage leads to 
several advantages over the pre-procedural MDCT. This 
technique is performed directly in the Angio Suite without 
patient repositioning. Thanks to these unique features it’s 
able to ameliorate procedural results by depicting occult 
nodules, tumor feeding vessels (intra- and extra-hepatic), 
best projection to aid catheterization. 
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Figure 3 Clinical case of intra-procedural advantages of CBCT guidance. (A) Pre-procedural MDCT show residual vital tissue (white 
arrow) after two sessions of DEB-TACE procedures within the posterior wall of the lesion located within segment VI; (B) intra-procedural 
CBCT acquired by injecting within the proper hepatic artery show lack of enhancement of the residual vital tissue target of treatment (white 
arrow); (C) DSA of the right surrenal artery that was demonstrated to fed the residual vital tissue; (D) 1-month follow-up MDCT show 
complete response, with no residual vital tissue. 
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